Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part I

CNS Neurol Disord Drug Targets. 2009 Mar;8(1):1-6. doi: 10.2174/187152709787601849.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Alzheimer Disease / immunology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / therapy*
  • Amyloid beta-Peptides / immunology*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Disease Models, Animal
  • Humans
  • Immunotherapy / methods*
  • Mice

Substances

  • Amyloid beta-Peptides